Free Writing Prospectus
Filed Pursuant to Rule 433
Reg-Statement No. 333-195645
USD 1.5bn 3.25% Fixed Rate Senior Notes due 2021
Pricing Term Sheet
| Issuer: | Barclays PLC | |
| Notes: | USD 1.5bn 3.25% Fixed Rate Senior Notes due 2021 | |
| Expected Issue Ratings1: | Baa3 (Moody’s) / BBB (S&P) / A (Fitch) | |
| Status: | Senior Debt / Unsecured | |
| Legal Format: | SEC registered | |
| Principal Amount: | USD 1,500,000,000 | |
| Trade Date: | January 5, 2016 | |
| Settlement Date: | January 12, 2016 (T+5) | |
| Maturity Date: | January 12, 2021 | |
| Coupon: | 3.25% | |
| Interest Payment Dates: | Semi-annually in arrear on July 12 and January 12 in each year, commencing on July 12, 2016 and ending on the Maturity Date | |
| Coupon Calculation: | 30/360, following, unadjusted | |
| Business Days: | New York, London | |
| U.K. Bail-in Power Acknowedgement: | Yes. See section entitled “Description of Senior Notes—Agreement with Respect to the Exercise of U.K. Bail-in Power” in the Preliminary Prospectus Supplement dated January 5, 2016 (the “Preliminary Prospectus Supplement”). | |
| Tax Redemption | If there is a Tax Event (as defined in the Preliminary Prospectus Supplement), the Issuer may, at its option, at any time, redeem the notes, in whole but not in part, at a redemption price equal to 100% of their principal amount, together with any accrued but unpaid interest to (but excluding) the date fixed for redemption, as further described and subject to the conditions specified in the Preliminary Prospectus Supplement. | |
| Benchmark Treasury: | T 1.75 12/31/20 | |
| Spread to Benchmark: | 155 bps | |
| Reoffer Yield: | 3.262% | |
| Issue Price: | 99.945% | |
| Underwriting Discount: | 0.325% | |
| Net Proceeds: | USD 1,494,300,000 | |
| Sole Bookrunner: | Barclays Capital Inc. | |
| 1 | Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. |
| Co-managers: | BMO Capital Markets Corp., Capital One Securities, Inc., CastleOak Securities, L.P., CAVU Securities, LLC, ING Financial Markets LLC, Loop Capital Markets LLC, Mizuho Securities USA Inc., nabSecurities, LLC, Natixis Securities America LLC, PNC Capital Markets LLC, Regions Securities LLC, Santander Investment Securities Inc., Scotia Capital (USA) Inc., Siebert Brandford Shank & Co., L.L.C., SMBC Nikko Securities America, Inc., Standard Chartered Bank, TD Securities (USA) LLC, U.S. Bancorp Investments, Inc., Wells Fargo Securities, LLC | |
| Risk Factors: | An investment in the notes involves risks. See “Risk Factors” section beginning on page S-6 of the Preliminary Prospectus Supplement. | |
| Denominations: | USD 200,000 and integral multiples of USD 1,000 in excess thereof | |
| ISIN/CUSIP: | US06738EAL92 / 06738E AL9 | |
| Settlement: | DTC; Book-entry; Transferable | |
| Documentation: | To be documented under the Issuer’s shelf registration statement on Form F-3 (No. 333-195645) and to be issued pursuant to the Senior Debt Indenture dated November 10, 2014 between the Issuer and The Bank of New York Mellon acting through its London Branch, as trustee (the “Trustee”) | |
| Listing: | We will apply to list the notes on the New York Stock Exchange | |
| Governing Law: | New York law | |
| Definitions: | Unless otherwise defined herein, all capitalized terms have the meaning set forth in the Preliminary Prospectus Supplement | |
The Issuer has filed a registration statement (including a prospectus dated May 2, 2014 (the “Prospectus”) and the Preliminary Prospectus Supplement) with the U.S. Securities and Exchange Commission (“SEC”) for this offering. Before you invest, you should read the Prospectus and the Preliminary Prospectus Supplement for this offering in that registration statement, and other documents the Issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by searching the SEC online database (EDGAR®) at www.sec.gov. Alternatively, you may obtain a copy of the Prospectus and the Preliminary Prospectus Supplement from Barclays Capital Inc. by calling 1-888-603-5847.
-2-